7Baggers
 c4 therapeutics announces clinical trial collaboration and  GlobeNewswire Thu, 02 Oct 2025 06:42:11 GMT
 c4 therapeutics : our corporate presentation (3f931d)  MarketScreener Wed, 01 Oct 2025 14:12:06 GMT
 Pfizer (PFE) Teams Up with C4 Therapeutics for Clinical Trial Co  GuruFocus Wed, 01 Oct 2025 12:15:40 GMT
 C4 Therapeutics Partners with Pfizer for Clinical Trial  TipRanks Wed, 01 Oct 2025 11:31:03 GMT
 C4 Therapeutics Announces Clinical Trial Collaboration and  GlobeNewswire Wed, 01 Oct 2025 11:03:48 GMT
 Why C4 Therapeutics Stock Crushed the Market on Monday  MSN Wed, 01 Oct 2025 01:34:56 GMT
 why c4 therapeutics stock crushed the market on monday  MSN Thu, 25 Sep 2025 05:19:46 GMT
 C4 Therapeutics (CCCC): Wells Fargo Raises Price Target to $10 |  GuruFocus Tue, 23 Sep 2025 13:48:45 GMT
 Barclays Raises Price Target for C4 Therapeutics (CCCC) in Lates  GuruFocus Tue, 23 Sep 2025 11:56:14 GMT
 c4 therapeutics stock price target raised to $10 by wells fargo on positive data  Investing.com South Africa Tue, 23 Sep 2025 11:29:34 GMT
 C4 Therapeutics Reports Promising Phase 1 Trial Results  The Globe and Mail Tue, 23 Sep 2025 07:00:00 GMT
 C4 Therapeutics (CCCC) Rating Reiterated by Stephens & Co. | CCC  GuruFocus Mon, 22 Sep 2025 13:19:41 GMT
 c4 therapeutics' (cccc) "overweight" rating reaffirmed at stephens  MarketBeat Mon, 22 Sep 2025 12:56:58 GMT
 c4 therapeutics' (cccc) overweight rating reiterated at stephens  MarketBeat Mon, 22 Sep 2025 12:56:58 GMT
 c4 therapeutics (nasdaq:cccc) coverage initiated at barclays  MarketBeat Mon, 22 Sep 2025 09:21:35 GMT
 c4 therapeutics (nasdaq:cccc) now covered by barclays  MarketBeat Mon, 22 Sep 2025 07:58:33 GMT
 C4’s multiple myeloma drug to reach pivotal trials after Phase I victory  Clinical Trials Arena Mon, 22 Sep 2025 07:00:00 GMT
 C4 Therapeutics Reports Promising Phase 1 Trial Results  TipRanks Mon, 22 Sep 2025 07:00:00 GMT
 C4 Therapeutics price target raised to $10 from $8 at Barclays  TipRanks Mon, 22 Sep 2025 07:00:00 GMT
 C4 Therapeutics presents data from Phase 1 trial of cemsidomide  TipRanks Sun, 21 Sep 2025 07:00:00 GMT
 morgan stanley maintains c4 therapeutics(cccc.us) with hold rating  富途牛牛 Sun, 21 Sep 2025 07:00:00 GMT
 c4 therapeutics (nasdaq:cccc) now covered by barclays  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 C4 Therapeutics Presents Cemsidomide Phase 1 Multiple  GlobeNewswire Sat, 20 Sep 2025 07:00:00 GMT
 c4 therapeutics’ myeloma drug shows 50% response rate in trial by investing.com  Investing.com Nigeria Sat, 20 Sep 2025 07:00:00 GMT
 c4 therapeutics (nasdaq:cccc) now covered by analysts at barclays  MarketBeat Fri, 19 Sep 2025 11:15:39 GMT
 barclays begins coverage on c4 therapeutics (nasdaq:cccc)  MarketBeat Fri, 19 Sep 2025 11:15:39 GMT
 c4 therapeutics (nasdaq:cccc) now covered by barclays  MarketBeat Fri, 19 Sep 2025 11:15:39 GMT
 c4 therapeutics (nasdaq:cccc) raised to "overweight" at stephens  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 c4 therapeutics (nasdaq:cccc) coverage initiated at barclays  MarketBeat Thu, 18 Sep 2025 12:16:02 GMT
 why ocugen stock zoomed 12% higher today  AOL.com Wed, 17 Sep 2025 18:28:29 GMT
 why roivant sciences stock is soaring today  AOL.com Wed, 17 Sep 2025 17:17:25 GMT
 Analyst Barclays Initiates Coverage on C4 Therapeutics (CCCC) wi  GuruFocus Wed, 17 Sep 2025 12:18:57 GMT
 barclays initiates c4 therapeutics at overweight with $8 price target  MarketScreener Wed, 17 Sep 2025 07:00:00 GMT
 c4 therapeutics initiated with an overweight at barclays  TipRanks Wed, 17 Sep 2025 01:17:09 GMT
 why dlocal stock topped the market on tuesday  AOL.com Wed, 17 Sep 2025 01:04:48 GMT
 c4 therapeutics stock plunges to 52-week low of $3.24  MSN Tue, 16 Sep 2025 18:20:27 GMT
 c4 therapeutics stock hits 52-week low at $3.38  MSN Tue, 16 Sep 2025 16:21:57 GMT
 stephens upgrades c4 therapeutics (nasdaq:cccc) to "overweight"  MarketBeat Tue, 16 Sep 2025 12:22:34 GMT
 C4 Therapeutics stock rating reiterated as Overweight by Barclays  Investing.com Tue, 16 Sep 2025 07:00:00 GMT
 C4 Therapeutics initiated with an Overweight at Barclays  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 why samsara stock is skyrocketing today  AOL.com Tue, 16 Sep 2025 00:38:56 GMT
 stephens & co. upgrades c4 therapeutics (cccc)  Nasdaq Tue, 16 Sep 2025 00:03:00 GMT
 why ocugen stock zoomed 12% higher today  AOL.com Mon, 15 Sep 2025 23:40:11 GMT
 why scholar rock stock bounced higher on monday  AOL.com Mon, 15 Sep 2025 21:29:43 GMT
 Why C4 Therapeutics Stock Crushed the Market on Monday  The Motley Fool Mon, 15 Sep 2025 07:00:00 GMT
 C4 Therapeutics stock surges after Stephens upgrade signals upside  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 why tempus ai stock soared nearly 14% higher today  AOL.com Thu, 11 Sep 2025 22:59:32 GMT
 192,424 shares in c4 therapeutics, inc. $cccc bought by nuveen llc  MarketBeat Thu, 11 Sep 2025 18:54:12 GMT
 nuveen llc buys new shares in c4 therapeutics, inc. $cccc  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 C4 Therapeutics Highlights Recent Achievement in Biogen Collaboration  Investing News Network Thu, 11 Sep 2025 00:52:18 GMT
 spotlight on aware and 2 other promising penny stocks  simplywall.st Wed, 10 Sep 2025 17:07:51 GMT
 nuveen llc makes new investment in c4 therapeutics, inc. $cccc  MarketBeat Wed, 10 Sep 2025 09:02:46 GMT
 is summit therapeutics a buy, sell, or hold now?  AOL.com Tue, 09 Sep 2025 10:19:17 GMT
 why waystar stock blasted nearly 10% higher on monday  AOL.com Mon, 08 Sep 2025 23:13:54 GMT
 nuveen llc invests $308,000 in c4 therapeutics, inc. $cccc  MarketBeat Mon, 08 Sep 2025 07:50:14 GMT
 why biontech stock crushed the market today  AOL.com Fri, 05 Sep 2025 21:18:00 GMT
 biogen’s ind for biib-142 accepted by fda  BioWorld MedTech Fri, 05 Sep 2025 07:00:00 GMT
 c4 therapeutics (cccc) receives buy rating from guggenheim | ccc  GuruFocus Thu, 04 Sep 2025 14:37:12 GMT
 c4 therapeutics initiated with a buy at guggenheim  TipRanks Thu, 04 Sep 2025 09:56:55 GMT
 c4 therapeutics highlights recent achievement in biogen collaboration  GlobeNewswire Thu, 04 Sep 2025 07:00:00 GMT
 C4 Therapeutics to Present Data from the Phase 1 Trial of  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 c4t to host webcast on cemsidomide multiple myeloma trial data  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 markets - medicine hat news  FinancialContent Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 09:26:19  beatles.ru Sun, 31 Aug 2025 06:26:21 GMT
 published on: 2025-08-30 06:24:58  beatles.ru Sat, 30 Aug 2025 02:24:58 GMT

C4 Therapeutics, Inc
(NASDAQ:CCCC) 

CCCC stock logo

C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in pr...

Founded: 2015
Full Time Employees: 88
CEO: Marc A. Cohen  
Sector: Other
Industry: Other

Share this website to your friends